Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Pain 5Neoplasms 5Pain, Intractable 3Agnosia 3Pain, Postoperative 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Spinal Stenosis 1Sezary Syndrome 1Primary Myelofibrosis 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Peripheral Nervous System Diseases 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Pain, Procedural 1Neurotoxicity Syndromes 1Myeloproliferative Disorders 1Mycosis Fungoides 1Multiple Myeloma 1Mucositis 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Radiotherapy 2Glutamine 2Fibroblast Growth Factor 7 2oxycodone-acetaminophen 1cyclohexaneacetic acid 1acetaminophen, hydrocodone drug combination 1Surveys and Questionnaires 1Sucralfate 1Standard of Care 1Passive Cutaneous Anaphylaxis 1Pain Management 1Neck Dissection 1Morphine 1Methods 1Methadone 1Laser Therapy 1Ketamine 1Ibuprofen 1Hydromorphone 1Gabapentin 1Fentanyl 1Educational Status 1Early Intervention, Educational 1Doxepin 1Cisplatin 1Benzydamine 1Analgesia 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Mucositis × Ketamine × Clear all
NCT00224692 2006-10-26

Analgesic Effect in Children of Low-Dose Ketamine for Mucositis Treated by Patient-Controlled Analgesia With Morphine

Assistance Publique - Hôpitaux de Paris

Phase 3 Terminated
50 enrolled
Other

Neoplasms, Pain, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡